Sanofi, GSK, Haleon extend selloff amid overhang from recalled heartburn drug

Aug. 11, 2022 8:13 AM ETSanofi (SNY)GSK, PFE, SNYNF, GCVRZ, HLNBy: Dulan Lokuwithana, SA News Editor42 Comments

Zantac

memoriesarecaptured/iStock Editorial via Getty Images

The ADRs of Sanofi (NASDAQ:SNY) (OTCPK:SNYNF) (GCVRZ), GSK (GSK), and Haleon (HLN) continued to trade lower in the pre-market Thursday as analysts flagged concerns over litigations related to recalled heartburn drug Zantac.

The H2 blocker, also

Recommended For You

Comments (42)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.